Publications by authors named "David Viola"

Claim this Profile
O
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience.
Agnese Proietti, Francesca Signorini, Riccardo Giannini, Anello Marcello Poma, Elisabetta Macerola, David Viola

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
Alan L Ho, Marek Dedecjus, Lori J Wirth, R Michael Tuttle, William B Inabnet, David Viola

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
David Viola, Anello Marcello Poma, Rossella Elisei, Fulvio Basolo

J Clin Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance in Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia.
Alessandro Prete, Antonio Matrone, Carla Gambale, Valeria Bottici, Virginia Cappagli, David Viola

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Yubing Tao, Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola

J Clin Endocrinol Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
Anello Marcello Poma, David Viola, Elisabetta Macerola, Agnese Proietti, Eleonora Molinaro

J Clin Endocrinol Metab· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors.
Loredana Lorusso, Cristina Romei, Paolo Piaggi, Chiara Fustini, Eleonora Molinaro, David Viola

Thyroid· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer.
Laura Valerio, Carlotta Giani, Laura Agate, Eleonora Molinaro, David Viola

Eur Thyroid J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.
Loredana Lorusso, Virginia Cappagli, Laura Valerio, Carlotta Giani, David Viola

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH.
Maria Cristina Campopiano, Debora Podestà, Francesca Bianchi, Carlotta Giani, Laura Agate, David Viola

Eur J Endocrinol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
Antonio Matrone, Alessio Faranda, Francesco Latrofa, Carla Gambale, Delio Stefani Donati, David Viola

J Clin Endocrinol Metab· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Prophylactic Central Compartment Lymph Node Dissection on the Outcome Of Patients With Papillary Thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases.
Luigi De Napoli, Antonio Matrone, Karin Favilla, Paolo Piaggi, David Galleri, David Viola

Endocr Pract· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
Eleonora Molinaro, Maria Cristina Campopiano, Letizia Pieruzzi, Antonio Matrone, Laura Agate, David Viola

J Clin Endocrinol Metab· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER.
Antonio Matrone, Carla Gambale, Liborio Torregrossa, Paolo Piaggi, Francesca Bianchi, David Viola

Endocr Pract· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kyeong J Kim, Sin G Kim, Jie Tan, Xiaopei Shen, David Viola

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response.
Laura Valerio, Valeria Bottici, Antonio Matrone, Paolo Piaggi, David Viola

Endocr Relat Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, David Viola

iScience· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations.
Rossella Elisei, Alessia Tacito, Teresa Ramone, Raffaele Ciampi, Valeria Bottici, David Viola

Genes (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer.
Eleonora Molinaro, David Viola, Nicola Viola, Pierpaolo Falcetta, Francesca Orsolini

Case Rep Endocrinol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease.
Konstantinos A Toulis, David Viola, George Gkoutos, Deepiksana Keerthy, Kristien Boelaert

Clin Endocrinol (Oxf)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases.
Rossella Elisei, Antonio Matrone, Laura Valerio, Eleonora Molinaro, Laura Agate, David Viola

J Clin Endocrinol Metab· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan.
Laura Agate, Francesca Bianchi, Federica Brozzi, Pierina Santini, Eleonora Molinaro, David Viola

Eur Thyroid J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Medullary Thyroid Cancer.
David Viola, Rossella Elisei

Endocrinol Metab Clin North Am· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment.
David Viola, Laura Agate, Eleonora Molinaro, Valeria Bottici, Loredana Lorusso

Front Endocrinol (Lausanne)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
Fei Wang, Shihua Zhao, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis